Merck & Co. Inc. buy Guggenheim
Start price
17.04.25
/
50%
€68.70
Target price
17.04.26
€101.20
Performance (%)
29.69%
Price
23.12.25
€89.10
Summary
This prediction is currently active. The prediction currently has a performance of 29.69%. This prediction currently runs until 17.04.26. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Merck & Co. Inc. | 3.244% | 3.244% |
| iShares Core DAX® | 0.224% | 2.457% |
| iShares Nasdaq 100 | 0.371% | -0.320% |
| iShares Nikkei 225® | 0.972% | -0.829% |
| iShares S&P 500 | 0.417% | -0.157% |
Comments by Guggenheim for this prediction
In the thread Merck & Co. Inc. diskutieren
Merck & Co., Inc. (NYSE: MRK) had its "buy" rating re-affirmed by analysts at Guggenheim. They now have a $115.00 price target on the stock.
Ratings data for MRK provided by MarketBeat
Stopped prediction by Guggenheim for Merck & Co. Inc.
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€94.60
06.11.24
06.11.24
€121.00
06.11.25
06.11.25
-21.04%
07.11.25
07.11.25
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€103.40
11.04.23
11.04.23
€113.61
11.04.24
11.04.24
13.73%
12.04.24
12.04.24

